Aimee Jones
Physician Assistant · Albuquerque, NMNPI 1124109616
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Exelixis Inc. at 42.5% of the total. Reporting peaked in 2023 at $2,488 and has fallen 82.9% since, to $426 in 2025. Among physician assistant clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $36.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$1K
- Johnson & Johnson$212
- Novartis$167
- Gilead$160
- Tempus AI, Inc$137
- Bristol Myers Squibb$113
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,22796%
- Education$1344%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 5 | $1,429 |
| Johnson & Johnson | 6 | $212 |
| Novartis | 7 | $167 |
| Gilead | 7 | $160 |
| Tempus AI, Inc | 2 | $137 |
| Bristol Myers Squibb | 5 | $113 |
| Eisai Inc. | 5 | $79 |
| Pharmacosmos Therapeutics Inc. | 4 | $71 |
| Seagen Inc. | 4 | $65 |
| Incyte Corporation | 3 | $60 |
| Karyopharm Therapeutics Inc. | 2 | $59 |
| Sobi, Inc | 3 | $58 |
| Pfizer | 3 | $56 |
| Merck | 3 | $56 |
| GSK | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| AstraZeneca | 3 | $50 |
| Array Biopharma Inc | 3 | $49 |
| Bayer | 3 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Stemline Therapeutics Inc. | 2 | $40 |
| AVEO Pharmaceuticals, Inc. | 1 | $40 |
| Amgen | 2 | $35 |
| Lilly USA, LLC | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $15 |
| Acrotech Biopharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,361 in reported general payments places this provider in the 90th percentile of 635 physician assistant providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 11 | $148,062 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Albuquerque
- Leigh HigginsAlbuquerque$10K
- Maria AbeytaAlbuquerque$8K
- Kari LavigneAlbuquerque$8K
- Elizabeth BelitzAlbuquerque$8K
- Desiree BarelaAlbuquerque$6K
- Stephanie BeyesAlbuquerque$5K
- Stephanie GonzalesAlbuquerque$5K
- Miquela WiegelAlbuquerque$5K
- Gabriela PobarAlbuquerque$5K
- Jacklyn ChavezAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.